Stryker, Johnson & Johnson and Zimmer Biomet posted their third quarter financial results, along with data on how their orthopedic segments performed.
Here is how their third-quarter finances compare:
Total sales: $4.5 billion (+7.7 percent)
Orthopedics and spine: $1.9 billion (+4.4 percent)
Hips: $347 million (+5.6 percent)
Knees: $481 million (+9.6 percent)
Total sales: $23.8 billion (+1.9 percent)
Spine, sports and other: $708 million (+0.3 percent)
Orthopedic: $2.0 billion (+0.1 percent)
Hips: $352 million (-0.9 percent)
Knees: $317 million (+0.4 percent)
Total sales: $1.7 billion (-0.9 percent)
Hips: $468 million (+3.1 percent)
Knees: $657 million (+1.4 percent)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $409.4 million (-6.4 percent)